Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Cardlytics
CDLX
Market cap
$64.9M
Overview
Fund Trends
Analyst Outlook
Journalist POV
1.20
USD
+0.12
11.11%
At close
Updated
Dec 3, 3:15 PM EST
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
11.11%
5 days
0%
1 month
-36.84%
3 months
34.85%
6 months
-29.41%
Year to date
-67.83%
1 year
-69.39%
5 years
-98.98%
10 years
-91.02%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
83.3%
Negative
Positive
Neutral
Negative
Positive
Zacks Investment Research
23 days ago
All You Need to Know About Cardlytics (CDLX) Rating Upgrade to Buy
Cardlytics (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Neutral
Seeking Alpha
27 days ago
Cardlytics, Inc. (CDLX) Q3 2025 Earnings Call Transcript
Cardlytics, Inc. ( CDLX ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Nick Lynton - Chief Legal & Privacy Officer and Secretary Amit Gupta - CEO & Director Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Q3 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on November 5, 2025.
Neutral
Business Wire
27 days ago
Cardlytics Announces Third Quarter 2025 Financial Results
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the third quarter ended September 30, 2025. "In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth," said Amit Gupta, CEO of Cardlytics. "We are moving forward with sharper focus and discipline, prioritizing initiatives that build on our fundamental strengths and wher.
Neutral
Business Wire
1 month ago
Cardlytics Announces Timing of Its Third Quarter 2025 Earnings Release
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be availabl.
Neutral
Business Wire
2 months ago
Cardlytics Announces Workforce Reductions As Part Of Organizational Realignment and Cost Savings Initiative
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced an enterprise-wide cost savings initiative aimed at optimizing its cost structure and aligning resources with its most critical business priorities. As part of this effort, Cardlytics reduced its workforce by approximately 120 full-time employees and contractors, representing about 30% of its total workforce. Cardlytics expects to incur $2.3 million in severance and related expenses in connection with this reduction, most.
Neutral
Business Wire
2 months ago
Cardlytics Repays 2020 Convertible Senior Notes Due 2025
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstanding of its 4.25% convertible senior notes due in 2029 and $50 million drawn on its line of credit. Cardlytics' cash and cash equivalents as of August 31, 2025 was $92.7 million a.
Neutral
Business Wire
3 months ago
Cardlytics Named “Best Digital Ad Network” in 2025 MarTech Breakthrough Awards Program
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced that Cardlytics' card-linked offer (CLO) network has won “Best Digital Ad Network” in the 2025 MarTech Breakthrough Awards program conducted by MarTech Breakthrough, a market intelligence organization that recognizes today's most innovative products, solutions, services and companies in the global field of Marketing, Sales and Ad Technology. Cardlytics' network was recognized for its pioneering approach to card-linked offe.
Neutral
The Motley Fool
3 months ago
Cardlytics (CDLX) Q2 Users Jump 19%
Cardlytics (CDLX) Q2 Users Jump 19%
Neutral
Seeking Alpha
3 months ago
Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript
Cardlytics, Inc. (NASDAQ:CDLX ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Alexis DeSieno - Chief Financial Officer Amit Gupta - CEO & Director Nick Lynton - Chief Legal & Privacy Officer and Secretary Conference Call Participants Cal Bartyzal - Unidentified Company Jacob Michael Stephan - Lake Street Capital Markets, LLC, Research Division Robert James Coolbrith - Evercore ISI Institutional Equities, Research Division Operator Good afternoon, ladies and gentlemen, and welcome to the Second Quarter 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, August 6 of 2025.
Negative
Zacks Investment Research
3 months ago
Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates
Cardlytics (CDLX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.15 per share a year ago.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close